| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Borgeson Blake is a Director at RECURSION PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $21.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 17, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $6.58 | $58,482.85 | -0.1% | +65.0% | +7.5% | |
| Oct 3, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $7.29 | $64,777.87 | -0.1% | +33.6% | -17.3% | |
| Sep 19, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $8.36 | $74,277.71 | -0.1% | +12.0% | -18.1% | |
| Sep 5, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $8.79 | $78,136.47 | -0.1% | -14.8% | -29.9% | |
| Aug 22, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $8.91 | $79,181.34 | -0.1% | -24.4% | -16.1% | |
| Aug 8, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 17,770 | $11.16 | $198,283.23 | -0.1% | -52.1% | -44.8% | |
| Jul 25, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 18,719 | $14.61 | $273,464.00 | -0.2% | -61.1% | -46.7% | |
| Jul 11, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $6.89 | $61,193.66 | -0.1% | -0.3% | +6.6% | |
| Jun 27, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $7.39 | $65,638.83 | -0.1% | +3.4% | +17.7% | |
| Jun 13, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 15,485 | $9.98 | $154,506.23 | -0.2% | -16.2% | -6.4% |